| Price | +/- | % +/- | Bid | Offer | Volume | High | Low | Last close |
|---|---|---|---|---|---|---|---|---|
| 1,254.00 |
|
+1.09% | 1,253.50 | 1,254.00 | 12,197,232 | 1,250.40 | 1,235.90 | 1,253.50 on 20-Nov-2009 |
| Time/Date | Price | Volume | Trade value | Type |
|---|---|---|---|---|
| 17:05:37 20-Nov-09 | 1,253.50 | 149 | 1,867.72 | NT |
| 16:38:43 20-Nov-09 | 1,249.66 | 100,000 | 1,249,660.00 | NT |
| 16:38:48 20-Nov-09 | 1,249.66 | 100,000 | 1,249,664.40 | C |
| 16:43:43 20-Nov-09 | 1,248.00 | 389,027 | 4,855,056.96 | NT |
| 16:36:12 20-Nov-09 | 1,252.87 | 9,200 | 115,264.04 | O |
| 21-Nov-2009 | |
|---|---|
| FTSE index | FTSE All-Share,FTSE Eurotop 300,FTSE 350 High Yield,FTSE 100,FTSE 350 (ex IT),FTSE techMARK All-Share,FTSE All-Share (ex IT),FTSE 350 |
| FTSE sector | Pharmaceuticals & Biotechnology |
| FTSE sub-sector | Pharmaceuticals |
| Country of share register | GB |
| Segment | SET0 |
| MiFID Status | Regulated Market |
| Exchange market size | 4,000 |
| SEDOL | 0925288 |
| ISIN number | GB0009252882 |
| Interim (£m) | 2008 (£m) | 2007 (£m) | 2006 (£m) | 2005 (£m) | |
|---|---|---|---|---|---|
| Currency | GBP | GBP | GBP | GBP | GBP |
| Total op. expenses | -10,068.00 | -17,752.00 | -15,598.00 | -15,724.00 | -15,150.00 |
| P/L for the financial year | 2,566.00 | 4,602.00 | 5,214.00 | 5,389.00 | 4,689.00 |
| Retained profit/loss | 980.00 | 1,673.00 | 2,421.00 | 2,791.00 | 2,299.00 |
| Total assets | 35,961.00 | 39,393.00 | 31,003.00 | 25,553.00 | 27,198.00 |
| Total liabilities | -35,961.00 | -39,393.00 | -31,003.00 | -25,553.00 | -27,198.00 |
| Time/Date | Headline |
|---|---|
| 17:14 18-Nov-09 | Blocklisting Interim Review |
| 17:49 11-Nov-09 | Director/PDMR Shareholding |
| 17:01 11-Nov-09 | Director/PDMR Shareholding |
| 15:13 09-Nov-09 | Director/PDMR Shareholding |
| 17:00 05-Nov-09 | Director/PDMR Shareholding |